Scientists have identified a gut protein that can prevent the development of Parkinson's disease (PD) by protecting against brain damage. This disease affects nearly 10 million people globally.
Parkinson's is
characterised by rigidity of muscle and tremors due to loss of dopamine in the
brain, and one of the reasons for that is toxin exposure.
In the study published
in the journal npj Parkinson's Disease, the team found that gut receptor
protein GUCY2C could prevent PD by protecting the brain from damage.
Dr Scott A. Waldman and
his team at Thomas Jefferson University have been studying GUCY2C, known for
its role in gut water and salt secretion, and found that it also present in the
brain.
They observed that
removing GUCY2C from gut cells in mice increased the expression of PD-related
genes, prompting them to investigate its role in the brain.
Collaborating with Dr.
Richard Smeyne, they discovered that mice without GUCY2C had more brain-cell
damage and were more toxin-susceptible than normal mice. When normal mice were
exposed to toxins, GUCY2C levels naturally increased, indicating a protective
role in neurons.
In human samples, PD
patients showed elevated GUCY2C levels compared to non-PD patients, puzzling
researchers. Current PD therapies manage symptoms by mimicking dopamine.
No comments:
Post a Comment